세계의 제약 막 여과 기술 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 재료별, 기술별, 용도별, 지역별, 경쟁별(2020-2030년)

Pharmaceutical Membrane Filtration Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Material by Technique, by Application, By Region & Competition, 2020-2030F

US $ 4,500 ￦ 6,233,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,619,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,082,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 제약 막 여과 기술 시장은 2024년에 58억 9,000만 달러로 평가되었고, 2030년까지 9.12%의 연평균 성장률(CAGR)로 성장할 것으로 예측되고 있습니다.

막 여과는 제약 제품의 분리, 정제, 멸균을 가능하게 함으로써 제약 제조 과정에서 핵심적인 역할을 합니다. 이 과정은 특정 성분을 선택적으로 통과시키며 오염 물질을 차단하는 다공성 막을 사용해 제품의 품질과 안전성을 보장합니다. 특히 무균 의약품 생산, 특히 주사제 및 안과용 용액에 있어 필수적입니다. 시장 성장은 고령화 인구, 만성 질환 발생률 증가, 글로벌 의료 접근성 향상으로 인한 제약 생산량 증가에 힘입고 있습니다. 백신, 단일 클론 항체, 바이오시밀러 등 바이오의약품에 대한 수요 증가도 고급 막 여과 기술의 필요성을 더욱 촉진하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	58억 9,000만 달러
시장 규모(2030년)	98억 7,000만 달러
CAGR(2025-2030년)	9.12%
급성장 부문	정밀 여과
최대 시장	북미

시장 성장 촉진요인

의약품 생산 증가

주요 시장 과제

규모 확대 과제

주요 시장 동향

아웃소싱 증가

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 제약 막 여과 기술 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 재료별(폴리에테르설폰(PES), 혼합 셀룰로오스 에스테르 및 셀룰로오스 아세테이트(MCE 및CA), 폴리불화비닐리덴(PVDF), 나일론 멤브레인 필터 등)
  • 기술별(정밀 여과, 초정밀 여과, 나노 여과, 기타)
  • 용도별(최종 제품 가공, 원료 여과, 세포 분리, 물 정화, 공기 정화)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 아시아태평양의 제약 막 여과 기술 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제7장 유럽의 제약 막 여과 기술 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제8장 북미의 제약 막 여과 기술 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제9장 남미의 제약 막 여과 기술 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 제약 막 여과 기술 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제13장 세계 제약 막 여과 기술 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제15장 PESTEL 분석

제16장 경쟁 구도

• 3M Company
• Danaher Corporation
• GE Healthcare
• GEA Group
• Graver Technologies
• Merck Millipore
• Parker Hannifin Corporation
• Repligen Corporation
• Sartorius Stedim Biotech GmbH
• Thermo Fisher Scientific Inc.

제17장 전략적 제안

제18장 기업 소개와 면책사항

HBR

영문 목차

영문목차

The Global Pharmaceutical Membrane Filtration Technologies Market was valued at USD 5.89 billion in 2024 and is expected to grow at a CAGR of 9.12% through 2030. Membrane filtration plays a pivotal role in pharmaceutical manufacturing by facilitating the separation, purification, and sterilization of pharmaceutical products. This process uses porous membranes to selectively allow specific components to pass while retaining contaminants, thus ensuring product quality and safety. It is especially critical for sterile drug production, including injectables and ophthalmic solutions. The market's expansion is fueled by rising pharmaceutical output, driven by an aging population, increased chronic disease incidence, and enhanced global healthcare access. The growing demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and biosimilars further propels the need for advanced membrane filtration. Regulatory pressures from agencies like the FDA and EMA also necessitate stringent contamination control, reinforcing the role of filtration technologies. Emerging markets and continuous innovations-such as Alfa Laval's 2022 launch of a multipurpose membrane system-are accelerating adoption, making membrane filtration an integral component of modern pharmaceutical production.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 5.89 Billion
Market Size 2030	USD 9.87 Billion
CAGR 2025-2030	9.12%
Fastest Growing Segment	Microfiltration
Largest Market	North America

Key Market Drivers

Rising Pharmaceutical Production

The consistent growth of the global pharmaceutical sector, fueled by rising population, aging demographics, and chronic illness prevalence, is a major driver for membrane filtration technologies. To meet rising demand, pharmaceutical firms are expanding production across drug categories-ranging from small molecules to complex biopharmaceuticals and vaccines. For instance, Meissner Corporation's USD 250 million investment in 2023 to build a U.S.-based facility highlights the focus on boosting microfiltration capabilities and ensuring supply chain resilience. Each drug type requires specific filtration processes for sterilization and purification, reinforcing the indispensable role of membrane technologies. Moreover, as biopharmaceutical production increases, so does the demand for high-performance filtration systems that ensure purity and safety. Maintaining product integrity and adhering to stringent regulatory standards make membrane filtration essential in safeguarding pharmaceutical quality during large-scale manufacturing.

Key Market Challenges

Scale-Up Challenges

Scaling membrane filtration systems from laboratory settings to full-scale production presents several technical and operational hurdles. Key variables such as membrane fouling, pressure dynamics, and mass transfer may behave unpredictably at larger scales, affecting filtration consistency. Fouling becomes more pronounced during scale-up, necessitating advanced mitigation strategies to maintain efficiency. Larger systems also introduce complex flow dynamics that require precise calibration to avoid membrane damage or suboptimal filtration. Regulatory validation of large-scale operations demands rigorous testing to prove reliability and adherence to quality standards. Moreover, membrane materials must withstand high operational stress over extended use. The scale-up process also raises cost concerns, involving higher capital expenditure, operating costs, and resource usage. Striking a balance between economic viability and process reliability remains a significant challenge for pharmaceutical manufacturers adopting large-scale membrane filtration.

Key Market Trends

Increased Outsourcing

The trend of outsourcing filtration processes to contract manufacturing organizations (CMOs) is gaining momentum in the pharmaceutical industry. CMOs offer expertise in membrane filtration technologies, enabling pharmaceutical firms to focus on core functions like drug development and marketing. These organizations provide scalable and cost-efficient solutions, often reducing capital investment burdens for pharma companies. By leveraging economies of scale and specialized infrastructure, CMOs offer flexibility in production and quicker adaptation to market demands. Moreover, their deep regulatory knowledge ensures compliance with GMP standards, easing the regulatory approval pathway. Outsourcing also minimizes operational risks, as CMOs often maintain backup systems to prevent disruptions. This growing reliance on third-party providers reflects a strategic shift toward efficiency, compliance, and scalability in pharmaceutical manufacturing.

Key Market Players

• 3M Company
• Danaher Corporation
• GE Healthcare
• GEA Group
• Graver Technologies
• Merck Millipore
• Parker Hannifin Corporation
• Repligen Corporation
• Sartorius Stedim Biotech GmbH
• Thermo Fisher Scientific Inc

Report Scope:

In this report, the Global Pharmaceutical Membrane Filtration Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Membrane Filtration Technologies Market, By Material:

• Polyethersulfone (PES)
• Mixed Cellulose Ester & Cellulose Acetate (MCE & CA)
• Polyvinylidene Difluoride (PVDF)
• Nylon Membrane Filters
• Others

Pharmaceutical Membrane Filtration Technologies Market, By Technique:

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Others

Pharmaceutical Membrane Filtration Technologies Market, By Application:

• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification

Pharmaceutical Membrane Filtration Technologies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Membrane Filtration Technologies Market.

Available Customizations:

Global Pharmaceutical Membrane Filtration Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Membrane Filtration Technologies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material (Polyethersulfone (PES), Mixed Cellulose Ester & Cellulose Acetate (MCE & CA), Polyvinylidene Difluoride (PVDF), Nylon Membrane Filters, others)
  • 5.2.2. By Technique (Microfiltration, Ultrafiltration, Nanofiltration, others)
  • 5.2.3. By Application (Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, Air Purification)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Pharmaceutical Membrane Filtration Technologies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
  • 6.3.2. India Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
  • 6.3.3. Australia Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
  • 6.3.4. Japan Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Material
      • 6.3.4.2.2. By Technique
      • 6.3.4.2.3. By Application
  • 6.3.5. South Korea Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Material
      • 6.3.5.2.2. By Technique
      • 6.3.5.2.3. By Application

7. Europe Pharmaceutical Membrane Filtration Technologies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
  • 7.3.3. Spain Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Material
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
  • 7.3.5. United Kingdom Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Material
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application

8. North America Pharmaceutical Membrane Filtration Technologies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
  • 8.3.2. Mexico Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
  • 8.3.3. Canada Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application

9. South America Pharmaceutical Membrane Filtration Technologies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application

10. Middle East and Africa Pharmaceutical Membrane Filtration Technologies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Material
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Material
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Material
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Pharmaceutical Membrane Filtration Technologies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Material
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Pharmaceutical Membrane Filtration Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. 3M Company
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Danaher Corporation
• 16.3. GE Healthcare
• 16.4. GEA Group
• 16.5. Graver Technologies
• 16.6. Merck Millipore
• 16.7. Parker Hannifin Corporation
• 16.8. Repligen Corporation
• 16.9. Sartorius Stedim Biotech GmbH
• 16.10.Thermo Fisher Scientific Inc.

17. Strategic Recommendations

18. About Us & Disclaimer

관련자료